New cytomegalovirus antiviral therapy: unlocking future prospects in treating cytomegalovirus-induced hemophagocytic lymphohistiocytosis.

IF 2.5 3区医学 Q3 PHARMACOLOGY & PHARMACY Expert Opinion on Pharmacotherapy Pub Date : 2025-02-01 Epub Date: 2025-01-23 DOI:10.1080/14656566.2025.2456586

Linn Åsholt Rolsdorph, Håkon Reikvam

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

新的巨细胞病毒抗病毒疗法：打开巨细胞病毒诱导的噬血细胞淋巴组织细胞病治疗的未来前景。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

相关文献

Organizational Factors

IF 0 Springer Series in Reliability EngineeringPub Date : 1900-01-01 DOI: 10.1007/978-3-030-90263-6_25

David Lapesa Barrera

Organizational competitiveness factors

IF 0 Brazilian Business ReviewPub Date : 2012-01-01 DOI: 10.15728/bbr.2012.9.1.2

D. Roman, Janaina Piana, Marielena Lozano, N. D. Mello, Rolf Hermann Erdmann

来源期刊

Expert Opinion on Pharmacotherapy 医学-药学

CiteScore

5.60

自引率

3.10%

发文量

163

审稿时长

4-8 weeks

期刊介绍： Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.